141 related articles for article (PubMed ID: 35381275)
1. High dose rate brachytherapy in the management of anal cancer: A review.
Ali ZS; Solomon E; Mann P; Wong S; Chan KKW; Taggar AS
Radiother Oncol; 2022 Jun; 171():43-52. PubMed ID: 35381275
[TBL] [Abstract][Full Text] [Related]
2. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers.
Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E
Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers.
Varela Cagetti L; Zemmour C; Salem N; Minsat M; Ferrè M; Mailleux H; Giovaninni M; Lelong B; De Chaisemartin C; Ries P; Poizat F; Tallet A; Moureau-Zabotto L
Brachytherapy; 2019; 18(6):814-822. PubMed ID: 31515067
[TBL] [Abstract][Full Text] [Related]
4. High-Dose-Rate Brachytherapy in the Management of Operable Rectal Cancer: A Systematic Review.
Buckley H; Wilson C; Ajithkumar T
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):111-127. PubMed ID: 28816137
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
[TBL] [Abstract][Full Text] [Related]
6. To evaluate the use of tandem and cylinder as an intracavitary brachytherapy device for carcinoma of the cervix with regard to local control and toxicities.
Gadda IR; Khan NA; Wani SQ; Baba MH
J Cancer Res Ther; 2022; 18(3):740-746. PubMed ID: 35900548
[TBL] [Abstract][Full Text] [Related]
7. Interstitial high-dose rate brachytherapy as boost for anal canal cancer.
Falk AT; Claren A; Benezery K; François E; Gautier M; Gerard JP; Hannoun-Levi JM
Radiat Oncol; 2014 Nov; 9():240. PubMed ID: 25377886
[TBL] [Abstract][Full Text] [Related]
8. Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal.
Kapp KS; Geyer E; Gebhart FH; Oechs AC; Berger A; Hebenstreit J; Stoeger H
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):997-1005. PubMed ID: 11240240
[TBL] [Abstract][Full Text] [Related]
9. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
[TBL] [Abstract][Full Text] [Related]
10. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
11. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
12. Outcome of 6 fractions of 5.3 Gray HDR brachytherapy in combination with external beam radiotherapy for treatment of cervical cancer.
Koh WY; Lim K; Tey J; Lee KM; Lim GH; Choo BA
Gynecol Oncol; 2013 Oct; 131(1):93-8. PubMed ID: 23906655
[TBL] [Abstract][Full Text] [Related]
13. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer.
Mohammed N; Kestin L; Ghilezan M; Krauss D; Vicini F; Brabbins D; Gustafson G; Ye H; Martinez A
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):204-12. PubMed ID: 21167653
[TBL] [Abstract][Full Text] [Related]
14. The impact of brachytherapy boost for anal canal cancers in the era of de-escalation treatments.
Varela Cagetti L; Moureau-Zabotto L; Zemmour C; Ferré M; Giovaninni M; Poizat F; Lelong B; De Chaisemartin C; Mitry E; Tyran M; Zioueche-Mottet A; Salem N; Tallet A
Brachytherapy; 2023; 22(4):531-541. PubMed ID: 37150739
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric and clinical outcome in image-based high-dose-rate interstitial brachytherapy for anal cancer.
Kapoor R; Khosla D; Shukla AK; Kumar R; Gupta R; Oinam AS; Sharma SC
Brachytherapy; 2014; 13(4):388-93. PubMed ID: 24211122
[TBL] [Abstract][Full Text] [Related]
16. High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.
Yamazaki H; Masui K; Suzuki G; Nakamura S; Yamada K; Okihara K; Shiraishi T; Yoshida K; Kotsuma T; Tanaka E; Otani K; Yoshioka Y; Ogawa K
Radiother Oncol; 2019 Mar; 132():162-170. PubMed ID: 30416045
[TBL] [Abstract][Full Text] [Related]
17. [Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Pène F; Schlienger M
Cancer Radiother; 2003 Aug; 7(4):237-53. PubMed ID: 12914857
[TBL] [Abstract][Full Text] [Related]
18. Fractionated perineal high-dose-rate temporary brachytherapy combined with external beam radiation in the treatment of localized prostate cancer: is lymph node sampling necessary?
Kovács G; Galalae R
Cancer Radiother; 2003 Apr; 7(2):100-6. PubMed ID: 12719039
[TBL] [Abstract][Full Text] [Related]
19. American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.
Mayadev J; Viswanathan A; Liu Y; Li CS; Albuquerque K; Damato AL; Beriwal S; Erickson B
Brachytherapy; 2017; 16(1):22-43. PubMed ID: 28109631
[TBL] [Abstract][Full Text] [Related]
20. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal.
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Huart J; Pène F; Schlienger M
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1259-73. PubMed ID: 12873670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]